BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld
BioWorld
June 27, 2006
View Archived Issues
Vasogen Again Battered By Negative Data On Celacade
Poor Celacade data sank shares of Vasogen Inc., though the company s top executive pointed to a bit of silver lining in this story. (BioWorld Today)
Read More
Metabolex's Multi-Part Deal With Ortho: $548M Potential
Read More
Anadys Suspending ANA975 Dosing; TLR7's Future Cloudy
Read More
Nastech, Amylin Nasal Byetta Partnership Has $89M Ceiling
Read More
Clinic Roundup
Read More
Other News To Note
Read More